Executive Briefings | May 15, 2018
For Addiction Treatment, Medication & Beyond
Use of medication for treating addiction on the increase. Over the past five years, we've seen the release of several new medications designed to address addiction (see FDA Approves New Opioid Addiction Treatment Combining Buprenorphine and Naloxone and FDA Approves Vivitrol for Opioid Dependence). And there are currently six new addiction treatment medications in late stage trials in the U.S. Food and Drug Administration (FDA) approval pipeline . . .